EU Policy
EU Policy 17/05/2012
Detecting and responding to outbreaks of HIV among people who inject drugs: best practices in HIV prevention and control
A joint meeting organised by ECDC and the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) was held in Tallinn, Estonia on 29–30 March 2012 to share best practice experiences on monitoring, and responding to the risk of HIV among people who inject drugs.
EU Policy 17/05/2012
Country mission Estonia: HIV, sexually transmitted infections, and hepatitis B and C
Following a request by the Estonian government, ECDC performed a follow-up country visit to Estonia covering HIV and sexually transmitted infections (STIs) from 11–13 October 2010, following an earlier visit in 2007.
EU Policy 17/05/2012
Country mission Romania: HIV, sexually transmitted infections, and hepatitis B and C
Following a request by the Romanian government, ECDC conducted a second follow-up country visit to Romania covering HIV, sexually transmitted infections (STIs) and hepatitis B and C from 11–13 May 2011.
EU Policy 17/05/2012
EU Parliament seeks urgent review of drug monitoring
A European Parliament committee has backed calls for action to improve the detection of potentially unsafe drugs and speed up action to take them off the market.
EU Policy 17/05/2012
European health sector improves despite crisis: Survey
European healthcare systems are defying budget cuts and the bite of continent-wide austerity programmes to deliver improving performances, according to the sixth Euro Health Consumer Index.
EU Policy 10/05/2012
Better use of data "will transform EU healthcare landscape"
Europeans will only be able to benefit from the affordable, less intrusive and more personalised healthcare which information and communication technologies (ICT) can bring if agreement is reached on how to use health data, experts have warned.
EU Policy 18/04/2012
Calls for greater public return on EU health R&D spend
The European Union has been urged to spearhead the adoption of new R&D models which "strive for more openness and needs-driven innovation to ensure affordable access to biomedical knowledge and goods".
EU Policy 17/04/2012
EU: Key committee urged to seek parliamentary rejection of ACTA
While the problems ACTA seeks to address are real, the unintended consequences with regard to individual criminalisation, the role of internet service providers, and the possible interruption of the transit of generic medicines are too grave.
EU Policy 16/04/2012
Changes coming for open access to research in Europe
Pressure is growing in Europe for open, free access to research results, particularly if they are publicly funded.
EU Policy 29/03/2012
European Parliament rejects referral of ACTA to EU High Court
The Committee of International Trade of the European Parliament voted against referring the Anti-Counterfeiting Trade Agreement (ACTA) to the European Court of Justice (ECJ).
EU Policy 12/03/2012
IMI to set up European Lead Factory for new drug opportunities
A new ‘European Lead Factory’ to be set up under the EU’s Innovative Medicines Initiative (IMI) will combine a library of as many as 500,000 drug candidates from industry and academia.
EU Policy 02/03/2012
Europe to speed pricing & reimbursement decisions
Member states to decide on pricing and reimbursement within 120 days if the drugs are innovative medicines and within 30 days for generics.
EU Policy 02/03/2012
European Parliament hears pitch for ACTA; But did it change minds?
Scepticism remains about ACTA's potential impact on digital freedoms and access to generic medicines in developing countries.
EU Policy 29/01/2012
European Parliament rapporteur quits in Acta protest
Negotiations over a controversial anti-piracy agreement have been described as a "masquerade" by a key Euro MP.
EU Policy 19/01/2012
EU needs united approach to fight fake drugs
The production and sale of counterfeit drugs is on the rise everywhere, with more unwary consumers buying them over the Internet.
EU Policy 16/01/2012
Danish EU presidency priorities include research, innovation, IP rights
Among Denmark’s many priorities for its six-month presidency of the European Union which started this month are advancing intellectual property rights, international trade, research and innovation. IP issues include a unitary EU patent, trademark rules modernisation, and orphan works legislation.
EU Policy 16/12/2011
Online tool to challenge health illiteracy
The European Commission next year plans to challenge poor health literacy levels in Europe with a new internet-based tool called Health in Europe: Information and Data Interface.
EU Policy 01/12/2011
EFPIA welcomes partnership commitment in Horizon 2020 proposal
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the continued commitment to public-private partnerships (PPPs) in Horizon 2020, the European Commission’s proposed €80 billion programme for investment in research and innovation.
EU Policy 25/10/2011
EU plans new clampdown on drugs
The European Commission proposes new plans to tackle the growing use of drugs in Europe, with the intent of countering the spread of new substances and the use of legal chemicals in the production of drugs such as cocaine or heroin.
EU Policy 17/10/2011
An EU financial transaction tax can be a champion for change in global health
Europe should allocate a proportion of the funds to development issues.
More...
